BACKGROUND: Gestational age at birth strongly predicts neonatal, adolescent and adult morbidity and mortality through mostly unknown mechanisms. Identification of specific genes that are undergoing regulatory change prior to birth, such as through changes in DNA methylation, would increase our understanding of developmental changes occurring during the third trimester and consequences of pre-term birth (PTB). METHODS: We performed a genome-wide analysis of DNA methylation (using microarrays, specifically CHARM 2.0) in 141 newborns collected in Baltimore, MD, using novel statistical methodology to identify genomic regions associated with gestational age at birth. Bisulphite pyrosequencing was used to validate significant differentially methylated regions (DMRs), and real-time PCR was performed to assess functional significance of differential methylation in a subset of newborns. RESULTS: We identified three DMRs at genome-wide significance levels adjacent to the NFIX, RAPGEF2 and MSRB3 genes. All three regions were validated by pyrosequencing, and RAGPEF2 also showed an inverse correlation between DNA methylation levels and gene expression levels. Although the three DMRs appear very dynamic with gestational age in our newborn sample, adult DNA methylation levels at these regions are stable and of equal or greater magnitude than the oldest neonate, directionally consistent with the gestational age results. CONCLUSIONS: We have identified three differentially methylated regions associated with gestational age at birth. All three nearby genes play important roles in the development of several organs, including skeletal muscle, brain and haematopoietic system. Therefore, they may provide initial insight into the basis of PTB's negative health outcomes. The genome-wide custom DNA methylation array technology and novel statistical methods employed in this study could constitute a model for epidemiologic studies of epigenetic variation.
BACKGROUND: Gestational age at birth strongly predicts neonatal, adolescent and adult morbidity and mortality through mostly unknown mechanisms. Identification of specific genes that are undergoing regulatory change prior to birth, such as through changes in DNA methylation, would increase our understanding of developmental changes occurring during the third trimester and consequences of pre-term birth (PTB). METHODS: We performed a genome-wide analysis of DNA methylation (using microarrays, specifically CHARM 2.0) in 141 newborns collected in Baltimore, MD, using novel statistical methodology to identify genomic regions associated with gestational age at birth. Bisulphite pyrosequencing was used to validate significant differentially methylated regions (DMRs), and real-time PCR was performed to assess functional significance of differential methylation in a subset of newborns. RESULTS: We identified three DMRs at genome-wide significance levels adjacent to the NFIX, RAPGEF2 and MSRB3 genes. All three regions were validated by pyrosequencing, and RAGPEF2 also showed an inverse correlation between DNA methylation levels and gene expression levels. Although the three DMRs appear very dynamic with gestational age in our newborn sample, adult DNA methylation levels at these regions are stable and of equal or greater magnitude than the oldest neonate, directionally consistent with the gestational age results. CONCLUSIONS: We have identified three differentially methylated regions associated with gestational age at birth. All three nearby genes play important roles in the development of several organs, including skeletal muscle, brain and haematopoietic system. Therefore, they may provide initial insight into the basis of PTB's negative health outcomes. The genome-wide custom DNA methylation array technology and novel statistical methods employed in this study could constitute a model for epidemiologic studies of epigenetic variation.
Authors: Rafael A Irizarry; Christine Ladd-Acosta; Benilton Carvalho; Hao Wu; Sheri A Brandenburg; Jeffrey A Jeddeloh; Bo Wen; Andrew P Feinberg Journal: Genome Res Date: 2008-03-03 Impact factor: 9.043
Authors: Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: Andrew E Jaffe; Peter Murakami; Hwajin Lee; Jeffrey T Leek; M Daniele Fallin; Andrew P Feinberg; Rafael A Irizarry Journal: Int J Epidemiol Date: 2012-02 Impact factor: 7.196
Authors: Kelly M Bakulski; HwaJin Lee; Jason I Feinberg; Ellen M Wells; Shannon Brown; Julie B Herbstman; Frank R Witter; Rolf U Halden; Kathleen Caldwell; Mary Ellen Mortensen; Andrew E Jaffe; John Moye; Laura E Caulfield; Yi Pan; Lynn R Goldman; Andrew P Feinberg; M Daniele Fallin Journal: Int J Epidemiol Date: 2015-04-22 Impact factor: 7.196
Authors: Stephanie M Engel; Bonnie R Joubert; Michael C Wu; Andrew F Olshan; Siri E Håberg; Per Magne Ueland; Wenche Nystad; Roy M Nilsen; Stein Emil Vollset; Shyamal D Peddada; Stephanie J London Journal: Am J Epidemiol Date: 2014-02-20 Impact factor: 4.897
Authors: Timothy P York; Shawn J Latendresse; Colleen Jackson-Cook; Dana M Lapato; Sara Moyer; Aaron R Wolen; Roxann Roberson-Nay; Elizabeth K Do; Susan K Murphy; Catherine Hoyo; Bernard F Fuemmeler; Jerome F Strauss Journal: Epigenetics Date: 2020-05-24 Impact factor: 4.528